Crewe Advisors LLC Bristol Myers Squibb CO Transaction History

Crewe Advisors LLC

$888 Million
Q2 2024

A detailed history of Crewe Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Crewe Advisors LLC holds 9,494 shares of BMY stock, worth $504,985. This represents 0.04% of its overall portfolio holdings.

Number of Shares

9,494

Previous 8,961 5.95%

Holding current value

$504,985

Previous $485,000 18.76%

% of portfolio

0.04%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$40.25 - $52.99 $21,453 - $28,243	533 Added 5.95%	9,494 $394,000
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $429,948 - $487,478	8,961 New	8,961 $485,000
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $89,576 - $99,460	-1,406 Reduced 12.7%	9,661 $617,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $20,304 - $23,029	-309 Reduced 2.72%	11,067 $767,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $30,062 - $35,598	439 Added 4.01%	11,376 $818,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $20 - $12,371	161 Added 1.49%	10,937 $778,000
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $93,897 - $103,414	1,293 Added 13.63%	10,776 $830,000
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $377,056 - $452,124	6,133 Added 183.07%	9,483 $693,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $80,445 - $93,780	1,500 Added 81.08%	3,350 $209,000
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $12,382 - $13,484	-200 Reduced 9.76%	1,850 $124,000
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $17,610 - $19,956	-305 Reduced 12.95%	2,050 $127,000
Q3 2020 Oct 13, 2020	BUY	$57.43 - $63.64 $10,854 - $12,027	189 Added 8.73%	2,355 $142,000
Q2 2020 Jul 24, 2020	SELL	$54.82 - $64.09 $27,300 - $31,916	-498 Reduced 18.69%	2,166 $127,000
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $787 - $1,027	16 Added 0.6%	2,664 $171,000
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $1,668 - $1,977	-39 Reduced 1.45%	2,648 $134,000
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $1,759 - $2,098	39 Added 1.47%	2,687 $128,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $158,721 - $173,046	2,648	2,648 $162,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.

Account

Crewe Advisors LLC Bristol Myers Squibb CO Transaction History